Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: A systematic review and meta-analysis

Urologia Internationalis

Volumn 90, Issue 3, 2013, Pages 339-347

  Yang, Lu ^a   Qian, Shengqiang ^a   Liu, Liangren ^a   Pu, Chunxiao ^a   Yuan, Haichao ^a   Han, Ping ^a   Wei, Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Erectile dysfunction; Phosphodiesterase 5 inhibitors; Prostate cancer; Radiotherapy; Randomized controlled trial

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BACKACHE; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EMBASE; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; GENITAL SYSTEM DISEASE ASSESSMENT; GLOBAL EFFICACY QUESTION; HEADACHE; HOT FLUSH; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERVENTION STUDY; MALE; MEDLINE; META ANALYSIS; MONOTHERAPY; MYALGIA; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL ENCOUNTER PROFILE; SEXUAL INTERCOURSE; SYSTEMATIC REVIEW; VISUAL DISORDER;

EID: 84876876665     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000343730     Document Type: Article

References (18)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 62: 69-90.
2. Ricardi U, Gontero P, Ciammella P, et al: Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: A randomized phase II trial. J Sex Med 2010; 7: 2851-2859.
3. Harrington C, Campbell G, Wynne C, Atkinson C: Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer. J Med Imaging Radiat Oncol 2010; 54: 224-228.
4. Peltier A, van Velthoven R, Roumeguere T: Current management of erectile dysfunction after cancer treatment. Curr Opin Oncol 2009; 21: 303-309.
5. Wespes E, Amar E, Hatzichristou D, et al: Guidelines on erectile dysfunction: An update. Eur Urol 2006; 49: 806-815.
6. Mendenhall WM, Henderson RH, Indelicato DJ, Keole SR, Mendenhall NP: Erectile dysfunction after radiotherapy for prostate cancer. Am J Clin Oncol 2009; 32: 443-447.
7. Bruner DW, James JL, Bryan CJ, et al: Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215. J Sex Med 2011; 8: 1228-1238.
8. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
9. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.4 updated March 2011. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org.
10. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
11. Incrocci L, Slagter C, Slob AK, Hop WCJ: A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis - ) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: 439-444.
12. Incrocci L, Koper PCM, Hop WCJ, Slob AK: Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: A randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys 2001; 51: 1190-1195.
13. Pinkawa M, Gagel B, Piroth MD, et al: Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009; 55: 227-234.
14. Ohebshalom M, Parker M, Guhring P, Mulhall JP: The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations. J Urol 2005; 174: 258-262.
15. Alicikus ZA, Yamada Y, Zhang Z, et al: Tenyear outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 2011; 117: 1429-1437.
16. McVary KT: Erectile dysfunction. N Engl J Med 2007; 357: 2472-2481.
17. Iacono F, Prezioso D, Somma P, Chierchia S, Galasso R, Micheli P: Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil. Urol Int 2008; 80: 249-252.
18. Nelson CJ, Weinberger MI, Balk E, Holland J, Breitbart W, Roth AJ: The chronology of distress, anxiety, and depression in older prostate cancer patients. Oncologist 2009; 14: 891-899.